HaloScape partners with Canary Speech to add voice biomarkers to health intelligence platform

  • HaloScape signed a strategic collaboration with Canary Speech to integrate vocal biomarker analysis into its AI health intelligence platform.
  • Voice-derived screening signals will be added across mood, stress, vocal energy, wellness, including mild cognitive impairment, spanning consumer and clinical workflows.
  • The companies will launch an ethics committee-approved clinical research program to validate Turkish-language voice biomarkers for GAD, major depressive disorder.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Canary Speech Inc. published the original content used to generate this news brief on June 03, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.